BioNxt Solutions (STU:BXT) GF Score: 25/100 (As of Aug. 13, 2026) — 32% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:BXT BioNxt Solutions Inc STU:BXT
25 GF Score
Price €0.21
! 4 Warning Signs
View Full Analysis

What is BioNxt Solutions GF Score?

BioNxt Solutions STU:BXT +3.78% 25 GF Score is 25 as of Aug. 13, 2026, which is 32% above its 10-year median of 19.00. GuruFocus rates STU:BXT with a GF Score™ of 25/100. The stock has 4 warning signs investors should review.

BioNxt Solutions has the GF Score of 25, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 2/10
5. Momentum Rank : 4/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes BioNxt Solutions might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

BioNxt Solutions  (STU:BXT) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

BioNxt Solutions GF Score Related Terms

STU:BXT vs ZTS: GF Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNxt Solutions GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's GF Score distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's GF Score falls into.


STU:BXT
25GF Score
BioNxt Solutions Inc STU:BXT
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 25 mean?
BioNxt Solutions (STU:BXT) has a GF Score of 25 as of Aug. 13, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on BioNxt Solutions and its competitors. This is 32% above median its historical median of 19.00. Over the past decade, BioNxt Solutions' GF Score has ranged from 2.00 to 51.00.
Is BioNxt Solutions' GF Score too high?
BioNxt Solutions' current GF Score of 25 is 32% above median its 10-year median of 19.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 51.00. Overall, BioNxt Solutions has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does BioNxt Solutions' GF Score compare to ZTS?
BioNxt Solutions' GF Score of 25 can be compared against companies in the Drug Manufacturers industry. Historically, BioNxt Solutions' own GF Score has ranged from 2.00 to 51.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on BioNxt Solutions and its competitors. BioNxt Solutions's current GF Score is 25, which is 32% above median its own 10-year median of 19.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNxt Solutions stock overvalued right now?
BioNxt Solutions (STU:BXT) has a current GF Score of 25. The current GF Score is 25, which is 32% above median its 10-year median of 19.00. BioNxt Solutions' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For BioNxt Solutions (STU:BXT), the current GF Score is 25 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioNxt Solutions Business Description

Other Exchanges BNXTF:USABNXT:Canada
Address 1928 Linden Road, Vancouver, BC, CAN, V6M 1E7
BioNxt Solutions Inc is is a bioscience innovator focused on next-generation drug delivery systems. With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, focused on European markets. The company is committed to improving healthcare by delivering precise, patient-centric solutions that enhance treatment outcomes. Its pipeline includes BNT23001, BNT23002, BNT24002, BNT24003, BNT24004. Its geographic areas are Austria, Germany, Switzerland regions.
25GF Score

Get the complete analysis for STU:BXT

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.21
Price